ArticleBMC research notes2024

Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study.

Carson K L Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.